Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antiangiogenic gene therapy enhances radiation-induced tumor vascular destruction

Oct. 28, 2002

Androgen receptor modulators prepared and tested at Ligand

Oct. 28, 2002

Two phase III trials of Xyotax in PS2 NSCLC patients to proceed

Oct. 28, 2002

Positive phase I results for Prima BioMed's dendritic cell-based therapy

Oct. 28, 2002

Novel antiproliferative agents prepared at Temple University

Oct. 25, 2002

Clofarabine enters phase I/II trial in combination with ara-C

Oct. 25, 2002

CYP1B1-activated prodrugs of antitumor compound identified by U. of London researchers

Oct. 25, 2002

AstraZeneca presents novel GnRH antagonists for cancer, BPH and uterine myoma

Oct. 25, 2002

Epothilones: multimedia presentation of mechanisms of action in Part II of an Integrity Case Study

Oct. 25, 2002

Enact reports titanium-based organometallic compounds as anticancer agents

Oct. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...